Organto Foods Announces Third Quarter 2025 Financial Results

Strengthened Balance Sheet and Continued Record Growth

TORONTO, ON AND BREDA, THE NETHERLANDS / ACCESS Newswire / November 18, 2025 / Organto Foods Inc. (TSX-V:OGO)(OTCQX:OGOFF)(FSE:OGF0) ("Organto" or "the Company"), is pleased to announce its financial results for the three and nine-month periods ended September 30, 2025. All amounts are expressed in Canadian dollars and in accordance with International Financial Reporting Standards (IFRS), except where specifically noted.

Hi-Lites

Quarter Ended September 30, 2025

• Third quarter sales of $15.1 million, an increase of 189% versus the prior year. Largest third quarter sales in the history of the Company.

• Gross profit of $1.2 million, an increase of 101% versus the prior year. Largest third quarter gross profit dollars in the history of the Company.

• Cash operating expenses of 8.7% of sales versus 18.2% in the prior year. Cash operating costs as percentage of sales improved as business scales and overheads are leveraged.

• EBITDA⁽¹⁾ (Earnings before interest, taxes, depreciation and amortization) of $(0.7) million, reflecting improved operating results offset by the impact of losses on derivatives used to manage currency risk.

Nine-Month Period Ended June 30, 2025

• Sales of $45.9 million, an increase of 222% versus the prior year, and already 122% greater than fiscal 2024 total sales of $20.7 million.

• Gross profit of $3.6 million, an increase of 208% versus the first nine months of the prior year, and already 100% greater than fiscal 2024 total gross profit of $1.8 million.

• Cash operating expenses of 7.3% of sales versus 13.4% in the prior year. Cash operating costs as percentage of sales demonstrate continued improvement as the business scales and overheads are leveraged.

• EBITDA⁽¹⁾ (Earnings before interest, taxes, depreciation and amortization) of $(0.9) million, reflecting improved operating results offset by the impact of losses on derivatives used to manage currency risk.

• Balance sheet significantly strengthened as a result of improved operations, debt restructuring and financing activities:

• Cash of $8.8 million (excluding restricted cash) versus $0.3 million at December 31, 2024.

• Working capital of $8.6 million versus negative working capital of $14.6 million at December 31, 2024.

• Short-term loans and convertible debentures reduced to $2.5 million versus $12.5 million at December 31, 2024.